CIHR releases research results to inform the development of benchmarks for wait times

November 16, 2005

OTTAWA (November 16, 2005) - The Canadian Institutes of Health Research (CIHR) released today research reports "Toward Canadian Benchmarks for Health Services Wait Times" in the areas of cancer, joint replacement and sight restoration.

CIHR, in partnership with the Provincial and Territorial Ministries of Health, funded eight Canadian research teams, based in British Columbia, Alberta, Saskatchewan, Manitoba, Ontario, Quebec, and Nova Scotia that carried out research regarding wait times for three of the five priority areas established in the Ten-Year Plan to Strengthen Health Care signed during the First Ministers Meeting in Ottawa, September 2004.

The research teams synthesized Canadian and international evidence from the best available research studies to help answer two questions: (1) what does existing research say about the relationship between clinical condition, wait times and health outcomes or quality of life for individuals waiting for treatment; and (2) what are the national or international wait time benchmarks (proposed or in use) for treatment, and what research evidence (if any) are they based on.

"This research will help inform the development of evidence-based benchmarks and identify key gaps where further research is needed in order to establish new benchmarks or to modify existing benchmarks as new evidence emerges," said Dr. Alan Bernstein, President of the Canadian Institutes of Health Research (CIHR). "The reports released today provide a good starting point. CIHR plans to continue working with all levels of government and other decision-makers to support research that will help set evidence-based benchmarks for wait times."

In December, CIHR's Institute of Health Services and Policy Research intends to issue a second call for research relating to the two questions above, in the clinical priority areas not initially funded: cardiac treatment, diagnostic imaging, and other types of, or treatments for, cancer. CIHR will also continue to fund research to break new ground in the science of evaluation and management of wait times for a variety of health care conditions and health care services.
-end-
The Canadian Institutes of Health Research (CIHR) is the Government of Canada's agency for health research. CIHR's mission is to create new scientific knowledge and to catalyze its translation into improved health, more effective health services and products, and a strengthened Canadian health care system. Composed of 13 Institutes, CIHR provides leadership and support to close to 10,000 health researchers and trainees across Canada. http://www.cihr-irsc.gc.ca

The following documents are available at: www.cihr-irsc.gc.ca

Summaries of research results on wait times for:
Cancer
Joint Replacement
Sight Restoration


Canadian Institutes of Health Research

Related Cancer Articles from Brightsurf:

New blood cancer treatment works by selectively interfering with cancer cell signalling
University of Alberta scientists have identified the mechanism of action behind a new type of precision cancer drug for blood cancers that is set for human trials, according to research published in Nature Communications.

UCI researchers uncover cancer cell vulnerabilities; may lead to better cancer therapies
A new University of California, Irvine-led study reveals a protein responsible for genetic changes resulting in a variety of cancers, may also be the key to more effective, targeted cancer therapy.

Breast cancer treatment costs highest among young women with metastic cancer
In a fight for their lives, young women, age 18-44, spend double the amount of older women to survive metastatic breast cancer, according to a large statewide study by the University of North Carolina at Chapel Hill.

Cancer mortality continues steady decline, driven by progress against lung cancer
The cancer death rate declined by 29% from 1991 to 2017, including a 2.2% drop from 2016 to 2017, the largest single-year drop in cancer mortality ever reported.

Stress in cervical cancer patients associated with higher risk of cancer-specific mortality
Psychological stress was associated with a higher risk of cancer-specific mortality in women diagnosed with cervical cancer.

Cancer-sniffing dogs 97% accurate in identifying lung cancer, according to study in JAOA
The next step will be to further fractionate the samples based on chemical and physical properties, presenting them back to the dogs until the specific biomarkers for each cancer are identified.

Moffitt Cancer Center researchers identify one way T cell function may fail in cancer
Moffitt Cancer Center researchers have discovered a mechanism by which one type of immune cell, CD8+ T cells, can become dysfunctional, impeding its ability to seek and kill cancer cells.

More cancer survivors, fewer cancer specialists point to challenge in meeting care needs
An aging population, a growing number of cancer survivors, and a projected shortage of cancer care providers will result in a challenge in delivering the care for cancer survivors in the United States if systemic changes are not made.

New cancer vaccine platform a potential tool for efficacious targeted cancer therapy
Researchers at the University of Helsinki have discovered a solution in the form of a cancer vaccine platform for improving the efficacy of oncolytic viruses used in cancer treatment.

American Cancer Society outlines blueprint for cancer control in the 21st century
The American Cancer Society is outlining its vision for cancer control in the decades ahead in a series of articles that forms the basis of a national cancer control plan.

Read More: Cancer News and Cancer Current Events
Brightsurf.com is a participant in the Amazon Services LLC Associates Program, an affiliate advertising program designed to provide a means for sites to earn advertising fees by advertising and linking to Amazon.com.